CacyBP/SIP protein is important for the proliferation of human glioma cells

IUBMB Life

Volumn 66, Issue 4, 2014, Pages 286-291

  Shi, Hengliang ^a   Gao, Yong ^a   Tang, Yuan ^a   Wu, Yuxuan ^a   Gong, Hui ^a   Du, Jin ^a   Zheng, Bao ^a   Hu, Jinxia ^a   Shi, Qiong ^a   Yu, Rutong ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

CacyBP SIP; cell cycle; glioma; proliferation

Indexed keywords

BETA CATENIN; BINDING PROTEIN; CALCYCLIN BINDING PROTEIN; PROTEIN KINASE B; PROTEIN P21; PROTEIN P53; SHORT HAIRPIN RNA; SIAH 1 INTERACTING PROTEIN; UNCLASSIFIED DRUG; CACYBP PROTEIN, HUMAN; CALCIUM BINDING PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GLIOMA CELL; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; UPREGULATION; ANTAGONISTS AND INHIBITORS; BRAIN; BRAIN TUMOR; CELL CYCLE; FLOW CYTOMETRY; GENETICS; GLIOMA; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; BRAIN; BRAIN NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL CYCLE; CELL PROLIFERATION; FLOW CYTOMETRY; GLIOMA; HUMANS; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84901047391     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1263     Document Type: Article

References (22)

1. Meyer, M. A., (2008) Malignant gliomas in adults. N. Engl. J. Med. 359, 1850; author reply 1850.
2. Buonerba, C., Di Lorenzo, G., Marinelli, A., Federico, P., Palmieri, G., et al. (2011) A comprehensive outlook on intracerebral therapy of malignant gliomas. Crit. Rev. Oncol./Hematol. 80, 54-68.
3. Sherman, J. H., Hoes, K., Marcus, J., Komotar, R. J., Brennan, C. W., et al. (2011) Neurosurgery for brain tumors: update on recent technical advances. Curr. Neurol. Neurosci. Rep. 11, 313-319.
4. Castro, M. G., Candolfi, M., Kroeger, K., King, G. D., Curtin, J. F., et al. (2011) Gene therapy and targeted toxins for glioma. Curr. Gene Ther. 11, 155-180.
5. Filipek, A., and, Wojda, U., (1996) p30, a novel protein target of mouse calcyclin (S100A6). Biochem. J. 320 (Part 2), 585-587.
6. Filipek, A., and, Kuznicki, J., (1998) Molecular cloning and expression of a mouse brain cDNA encoding a novel protein target of calcyclin. J. Neurochem. 70, 1793-1798. (Pubitemid 28207800)
7. Matsuzawa, S. I., and, Reed, J. C., (2001) Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses. Mol. Cell 7, 915-926. (Pubitemid 32525739)
8. Filipek, A., Jastrzebska, B., Nowotny, M., and, Kuznicki, J., (2002) CacyBP/SIP, a calcyclin and Siah-1-interacting protein, binds EF-hand proteins of the S100 family. J. Biol. Chem. 277, 28848-28852.
9. Schneider, G., Nieznanski, K., Jozwiak, J., Slomnicki, L. P., Redowicz, M. J., et al. (2010) Tubulin binding protein, CacyBP/SIP, induces actin polymerization and may link actin and tubulin cytoskeletons. Biochim. Biophys. Acta 1803, 1308-1317.
10. Kilanczyk, E., Filipek, S., Jastrzebska, B., and, Filipek, A., (2009) CacyBP/SIP binds ERK1/2 and affects transcriptional activity of Elk-1. Biochem. Biophys. Res. Commun. 380, 54-59.
11. Xia, Z. B., Dai, M. S., Magoulas, C., Broxmeyer, H. E., and, Lu, L., (2000) Differentially expressed genes during in vitro differentiation of murine embryonic stem cells transduced with a human erythropoietin receptor cDNA. J. Hematother. Stem Cell Res. 9, 651-658.
12. Pircher, T. J., Geiger, J. N., Zhang, D., Miller, C. P., Gaines, P., et al. (2001) Integrative signaling by minimal erythropoietin receptor forms and c-Kit. J. Biol. Chem. 276, 8995-9002.
13. Au, K. W., Kou, C. Y., Woo, A. Y., Chim, S. S., Fung, K. P., et al. (2006) Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes. J. Cell. Biochem. 98, 555-566. (Pubitemid 43727175)
14. Chen, X., Han, G., Zhai, H., Zhang, F., Wang, J., et al. (2008) Expression and clinical significance of CacyBP/SIP in pancreatic cancer. Pancreatology 8, 470-477.
15. Zhai, H., Shi, Y., Jin, H., Li, Y., Lu, Y., et al. (2008) Expression of calcyclin-binding protein/Siah-1 interacting protein in normal and malignant human tissues: an immunohistochemical survey. J. Histochem. Cytochem. 56, 765-772. (Pubitemid 351991089)
16. Herington, J. L., Bi, J., Martin, J. D., and, Bany, B. M., (2007) β-Catenin (CTNNB1) in the mouse uterus during decidualization and the potential role of two pathways in regulating its degradation. J. Histochem. Cytochem. 55, 963-974. (Pubitemid 47293842)
17. Chen, X., Mo, P., Li, X., Zheng, P., Zhao, L., et al. (2011) CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells. Mol. Carcinog. 50, 804-810.
18. Ning, X., Sun, S., Hong, L., Liang, J., Liu, L., et al. (2007) Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol. Cancer Res. 5, 1254-1262.
19. Mezhybovska, M., Wikstrom, K., Ohd, J. F., and, Sjolander, A., (2006) The inflammatory mediator leukotriene D4 induces β-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells. J. Biol. Chem. 281, 6776-6784. (Pubitemid 43847614)
20. Sangkhathat, S., Kusafuka, T., Miao, J., Yoneda, A., Nara, K., et al. (2006) In vitro RNA interference against β-catenin inhibits the proliferation of pediatric hepatic tumors. Int. J Oncol. 28, 715-722.
21. Vousden, K. H., and, Lane, D. P., (2007) p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275-283. (Pubitemid 46474662)
22. Levine, A. J., and, Oren, M., (2009) The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer 9, 749-758.